Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction during the study was a skin bruise at the
injection site.
The table below shows the adverse reactions that happened during the study.
Most common adverse reactions during the study
30 mg 100 mg 300 mg 600 mg
MEDI5884 MEDI5884 MEDI5884 MEDI5884 Placebo
(out of 12 (out of 12 (out of 12 (out of 12 (out of 16
participants) participants) participants) participants) participants)
Skin bruise at
the injection 0.0% (0) 8.3% (1) 0.0% (0) 16.7% (2) 0.0% (0)
site
Redness at the
0.0% (0) 8.3% (1) 0.0% (0) 8.3% (1) 0.0% (0)
injection site
Pain at the
0.0% (0) 8.3% (1) 0.0% (0) 8.3% (1) 0.0% (0)
injection site
Nausea 8.3% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Headache 0.0% (0) 8.3% (1) 0.0% (0) 0.0% (0) 0.0% (0)
Itching at the
0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 6.3% (1)
injection site
How has this study helped patients and
researchers?
This study helped researchers learn how MEDI5884 affects cholesterol levels in
healthy participants, and about the safety of MEDI5884.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI5884 are planned.
11